Probe combination for diagnosing fibula amyotrophy, kit and application
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- THE THIRD XIANGYA HOSPITAL OF CENT SOUTH UNIV
- Publication Date
- 2022-04-05
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of gene detection, and in particular relates to a probe combination, a kit and an application for diagnosing Charcot-Marie-Tooth disease. Background technique
[0002] Charcot-marie-tooth disease (CMT) is the most common group of hereditary peripheral neuropathies with high clinical and genetic heterogeneity, and its overall incidence is about 1 / 2500. According to the median motor nerve conduction velocity (MNCV), CMT can be further subdivided into demyelinating (CMT1, MNCV≤38m / s), axonal (CMT2, MNCV>38m / s) and intermediate There are three types (ICMT, 25m / s<MNCV<45m / s). So far, more than 100 genes have been identified to be associated with CMT, among which: PMP22 is the most common gene in CMT type 1, followed by MPZ; MFN2 is the most common gene in CMT type 2 and GJB1 is the most common gene in CMT intermediate type. According to literature reports, PMP22, GJB1, MPZ and MFN2 are the four most co...